Explore 3 Stock Ideas & Industry Insights Download Free Report

News

State Street Reports 5% Stake in Cisco Systems

State Street Corporation filed a Schedule 13G with the U.S. Securities and Exchange Commission on November 9, 2026, disclosing its beneficial ownership position in Cisco Systems Inc as of September 30, 2026.

Manish Choudhary | 10 November 2026

State Street Reports 5.4% Stake in Collegium Pharmaceutical

State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing a beneficial ownership position in Collegium Pharmaceutical Inc as of September 30, 2026.

Vinay Lochav | 10 November 2026

State Street Reports 4.7% Stake in Commerce Bancshares

State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing a beneficial ownership position in the common stock of Commerce Bancshares Inc/MO as of September 30, 2026.

Aakashdeep | 10 November 2026

WhiteFiber Files Q3 2026 Report With 45.3M Shares Out

WhiteFiber, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 10, 2026, covering the company's financial condition and operations as a data center and cloud services provider.

Vinay Lochav | 10 November 2026

Cellectar Biosciences Q3 2026: Cash Rises to $24.6M

Cellectar Biosciences, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 10, 2026, reporting condensed consolidated financial statements and related disclosures.

Aakashdeep | 10 November 2026

State Street Reports 4.7% Stake in Cullen/Frost Bankers

State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 2,930,133 shares of Cullen/Frost Bankers Inc common stock as of September 30, 2026.

Anjali Anand | 10 November 2026

State Street Discloses 5.1% Stake in Contango Silver & Gold

State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 1,717,200 shares of common stock in Contango Silver & Gold Inc., representing 5.1% of the class, as of the triggering event date of September 30, 2026.

Nitish Kishor | 10 November 2026

State Street Reports 4.3% Stake in Compass Therapeutics

State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 7,737,938 shares of Compass Therapeutics Inc common stock as of September 30, 2026.

Shwetambri Chauhan | 10 November 2026

State Street Reports 4% Stake in Corvus Pharmaceuticals

State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 3,331,535 shares of Corvus Pharmaceuticals Inc. common stock as of September 30, 2026.

Aakashdeep | 10 November 2026

State Street Reports 5.2% Stake in CRISPR Therapeutics

State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 4,994,047 shares of CRISPR Therapeutics AG common stock as of September 30, 2026.

Aakashdeep | 10 November 2026
Support

Hi! How can we help you today?

Loading…